Drug-induced pulmonary edema and acute respiratory distress syndrome

Clinics in Chest Medicine

Volumn 25, Issue 1, 2004, Pages 95-104

  Lee Chiong Jr , Teofilo ^a   Matthay, Richard A ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALITRETINOIN; AMLODIPINE; ANALGESIC AGENT; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CONTRAST MEDIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; DIURETIC AGENT; GEMCITABINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; METHOTREXATE; MITOMYCIN; MITOMYCIN C; NIFEDIPINE; OKT 3; PENTOSTATIN; PLACEBO; RESPIRATORY TRACT AGENT; RETINOIC ACID; TAMOXIFEN; UNINDEXED DRUG; URINARY TRACT AGENT; VERAPAMIL; VINBLASTINE;

ABNORMAL RESPIRATORY SOUND; ACUTE RESPIRATORY FAILURE; ANAPHYLAXIS; BLOOD TOXICITY; BRONCHUS; CAPILLARY LEAK SYNDROME; CARDIOMEGALY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; COUGHING; CYTOTOXICITY; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DNA SYNTHESIS; DRUG FATALITY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; FEVER; FLUID RETENTION; GASTROINTESTINAL TOXICITY; GLOMUS TUMOR; GRAFT REJECTION; HEART; HEART AFTERLOAD; HEART FAILURE; HEART MUSCLE COMPLIANCE; HEART OUTPUT; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; HYPERVENTILATION; HYPERVOLEMIA; HYPOTENSION; HYPOXEMIA; HYPOXIA; INTERSTITIAL LUNG DISEASE; KIDNEY CARCINOMA; LABORATORY TEST; LEUKEMIA; LEUKOCYTOSIS; LUNG ALVEOLUS; LUNG BLOOD VOLUME; LUNG EDEMA; LUNG FUNCTION TEST; LUNG INFILTRATE; LUNG INTERSTITIUM; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; LYMPHOPROLIFERATIVE DISEASE; MEASUREMENT; MELANOMA; METASTASIS; MYDRIASIS; MYOCARDITIS; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PERIBRONCHIAL CUFFING; PLEURA EFFUSION; PRIORITY JOURNAL; PROVOCATION TEST; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; SYNDROME; TACHYCARDIA; TACHYPNEA; THORAX; THORAX PAIN; THORAX RADIOGRAPHY; TOXICITY; TRANS RETINOIC ACID SYNDROME; URINARY EXCRETION; URINE OSMOLALITY; VASCULAR RESISTANCE; WEIGHT GAIN;

ANTINEOPLASTIC AGENTS; CHLOROTHIAZIDE; CONTRAST MEDIA; DIURETICS; ETHCHLORVYNOL; HUMANS; HYPNOTICS AND SEDATIVES; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE AGENTS; LUNG; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; SODIUM CHLORIDE SYMPORTER INHIBITORS; TOCOLYTIC AGENTS; TRETINOIN;

EID: 1542332727     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(03)00128-X     Document Type: Review

References (69)

1. Levy GJ, Shabot MM, Hart ME, Mya WW, Goldfinger D. Tranfusion-associated noncardiogenic pulmonary edema. Report of a case and a warning regarding treatment. Transfusion 1986;26:278-81.
2. Thomson MICROMEDEX. MICROMEDEX Healthcare Series, vol. 117. Montvale (NJ): Thomson Medical Economics; 2003.
3. 2004 Physicians' Desk Reference. Montvale (NJ): Thomson Medical Economics; 2003.
4. Haupt HM, Hutchins GM, Moore GW. Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia. Am J Med 1981;70(2):256-61.
5. Conant EF, Fox KR, Miller WT. Pulmonary edema as a complication of interleukin-2 therapy. AJR Am J Roentgenol 1989;152(4):749-52.
6. Lascari AD, Strano AJ, Johnson WW, Collins JG. Methotrexate-induced sudden fatal pulmonary reaction. Cancer 1977;40(4):1393-7.
7. Rao SX, Ramaswamy G, Levin M, McCravey JW. Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma. Arch Intern Med 1985;145:1905-7.
8. Lagler U, Gattiker HH. Acute dyspnea following intravenous administration of vinblastine/mitomycin C. Schweiz Med Wochenschr 1989;119(9):290-2.
9. Golfieri R, Giampalma E, Lalli A, Sama C, Venturoli N, Mazziotti A, et al. Pulmonary complications from monoclonal antibody (OKT3) immunosuppression in patients who have undergone an orthotopic liver transplant. Radiol Med (Torino) 1994;87(1- 2):58-64.
10. Koller CA, Mitchell BS. Alterations in erythrocyte adenine nucleotide pools resulting from 2′-deoxycoformycin therapy. Cancer Res 1983;43(3):1409-14.
11. Jung JI, Choi JE, Hahn ST, Min CK, Kim CC, Park SH. Radiologic features of all-trans-retinoic acid syndrome. AJR Am J Roentgenol 2002;178(2):475-80.
12. Lawrence JA, Adamson PC, Caruso R, Chow C, Kleiner D, Murphy RF, et al. Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations. J Clin Oncol 2001;19(10):2754-63.
13. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 1996;335(15):1107-14.
14. Batra AK, Segall PH, Ahmed T. Pulmonary edema with nifedipine in primary pulmonary hypertension. Respiration 1985;47:161-3.
15. Brass BJ, Winchester-Penny S, Lipper BL. Massive verapamil overdose complicated by noncardiogenic pulmonary edema. Am J Emerg Med 1996;14(5):459-61.
16. Liu HP, Wu KC, Lu PP, Lin WT, Wang YL, Li AH, et al. Delayed-onset epinephrine-induced pulmonary edema. Anesthesiology 1999;91(4):1169-70.
17. Krovvidi H, Kulkarni PR. Management of intraoperative pulmonary oedema in a child following systemic absorption of phenylephrine eyedrops. Br J Anaesth 2002;89(2):343.
18. Wark JD, Larkins RG. Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma. BMJ 1978;1(6124):1395-6.
19. Desai SP, Pierce Jr EC, Fleming TC. Severe hypertension, propranolol, and acute pulmonary edema. Crit Care Med 1987;15(8):799-800.
20. Farber HW, Graven KK, Kokolski G, Korn JH. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma. J Rheumatol 1999;26(5):1195-6.
21. Palmer SM, Robinson LJ, Wang AD, Gossage JR, Bashore T, Tapson SF. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest 1998;113:237-40.
22. Preston IR, Klinger JR, Houtchens J, Nelson D, Mehta S, Hill NS. Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome. Chest 2002;121(2):656-9.
23. Gallerani M, Manzoli N, Fellin R, Simonato M, Orzincolo C. Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. Am J Emerg Med 2002;20(4):371-2.
24. Steinberg AD. Pulmonary edema following ingestion of hydrochlorothiazide. JAMA 1968;204(9):825-7.
25. Bowden FJ. Non-cardiogenic pulmonary oedema after ingestion of chlorothiazide. BMJ 1989;298:60.
26. Mas A, Jordana R, Valles J, Cervantes M. Recurrent hydrochlorothiazide- induced pulmonary edema. Intensive Care Med 1998;24(4):363-5.
27. Hoegholm A, Rasmussen SW, Kristensen KS. Pulmonary oedema with shock induced by hydrochlorothiazide: a rare side effect mimicking myocardial infarction. Br Heart J 1990;63(3):186.
28. Shieh CM, Chen CH, Tao CW, Tsai JJ, Perng RP. Hydrochlorothiazide- induced pulmonary edema: a case report and literature review. Zhonghua Yi Xue Za Zhi (Taipei) 1992;50(6):495-9.
29. Klein MD. Noncardiogenic pulmonary edema following hydrochlorothiazide ingestion. Ann Emerg Med 1987;16(8):901-3.
30. Bernal C, Patarca R. Hydrochlorothiazide-induced pulmonary edema and associated immunologic changes. Ann Pharmacother 1999;33(2):172-4.
31. Conces Jr DJ, Kreipke DL, Tarver RD. Pulmonary edema induced by intravenous ethchlorvynol. Am J Emerg Med 1986;4(6):549-51.
32. Fischer P, Glauser FL, Millen JE, Lewis J, Egan P. The effects of ethchlorvynol on pulmonary alveolar membrane permeability. Am Rev Respir Dis 1977;116(5):901-6.
33. Gil J, McNiff JM. Early tissue damage in ethchlorvynol-induced alveolar edema in rabbit lung. Am Rev Respir Dis 1982;126(4):701-7.
34. Sprague RS, Stephenson AH, Dahms TE, Lonigro AJ. Effect of cyclooxygenase inhibition on ethchlorvynolinduced acute lung injury in dogs. J Appl Physiol 1986;61(3):1058-64.
35. Fairman RP, Falls R, Millen JE, Glauser FL. Histamine receptor and prostaglandin synthetase blockers in ethchlorvynol-induced pulmonary edema in canines. Clin Toxicol 1980;16(1):25-31.
36. Sprague RS, Stephenson AH, McMurdo L, Lonigro AJ. Inhibition of nitric oxide synthesis improves arterial oxygenation in ethchlorvynol-induced acute lung injury in dogs. Pol J Pharmacol 1995;47(5):473-8.
37. Li C, Gefter WB. Acute pulmonary edema induced by overdosage of phenothiazines. Chest 1992;101(1):102-4.
38. Shannon M, Lovejoy Jr FH. Pulmonary consequences of severe tricyclic antidepressant ingestion. J Toxicol Clin Toxicol 1987;25(6):443-61.
39. Tweeddale MG. Salicylates and pulmonary edema. Ann Intern Med 1974;81:710-1.
40. Heffner JE, Sahn SA. Salicylate-induced pulmonary edema. Clinical features and prognosis. Ann Intern Med 1981;95(4):405-9.
41. Kjeldgaard JM. Methadone-induced pulmonary edema. JAMA 1971;218:882.
42. Master K. Narcotics and pulmonary edema. Ann Intern Med 1972;77:817.
43. Fisch HP, Wands J, Yeung J, Davis PJ. Pulmonary edema and disseminated intravascular coagulation after intravenous abuse of d-propoxyphene (darvon). South Med J 1972;65(4):493-5.
44. Davies AE, Robertson MJ. Pulmonary oedema after the administration of intravenous salbutamol and ergometrine. Case report. Br J Obstet Gynaecol 1980;87(6):539-41.
45. Shahin J, Guharoy SR. Pulmonary edema possibly developing secondary to the intravenous administration of oxytocin. Vet Hum Toxicol 1991;33(6):587-8.
46. Pisani RJ, Rosenow EC. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989;110:714-8.
47. Nimrod C, Rambihar V, Fallen E, Effer S, Cairns J. Pulmonary edema associated with isoxsuprine therapy. Am J Obstet Gynecol 1984;148:625-9.
48. Fenske M, Grospietsch G, Dietrich B, Ensink FB, Holzl M, Kuhn W. Fenoterol-induced changes of urine excretion, body weight, blood hematocrit, hemoglobin, total protein values and serum electrolyte levels in pregnant rabbits. Gynecol Obstet Invest 1982;14(4):273-82.
49. Russi EW, Spaetling L, Gmur J, Schneider H. High permeability pulmonary edema (ARDS) during tocolytic therapy- a case report. J Perinat Med 1988;16(1):45-9.
50. Drault JN, Kaidomar S, Schaub B, Mehdaoui H, Herbland A, Cidolit E. Acute pulmonary edema caused by tocolytic therapy with salbutamol. Presse Med 2001;30(3):112-4.
51. Armson BA, Samuels P, Miller F, Verbalis J, Main EK. Evaluation of maternal fluid dynamics during tocolytic therapy with ritodrine hydrochloride and magnesium sulfate. Am J Obstet Gynecol 1992;167(3):758-65.
52. Turner E, Rathgeber J, Kittel E, Grospietsch G, Braun U. Fenoterol (Partusisten)-associated lung edema. A case report. Anaesthesist 1986;35(4):258-60.
53. Kozlowski C, Kollef MH. Noncardiogenic pulmonary edema associated with intravenous radiocontrast administration. Chest 1992;102(2):620-1.
54. Paul RE, George G. Fatal non-cardiogenic pulmonary oedema after intravenous non-ionic radiographic contrast. Lancet 2002;359(9311):1037-8.
55. Mare K, Violante M, Zack A. Pulmonary edema following high intravenous doses of diatrizoate in the rat. Effects of corticosteroid pretreatment. Acta Radiol Diagn (Stockh) 1985;26(4):477-82.
56. Allred RJ, Ewer S. Fatal pulmonary edema following intravenous "freebase" cocaine use. Ann Emerg Med 1981;10(8):441-2.
57. Efferen L, Palat D, Meisner J. Nonfatal pulmonary edema following cocaine smoking. N Y State J Med 1989;89(7):415-6.
58. Katz S, Aberman A, Frand UI, Stein IM, Fulop M. Heroin pulmonary edema. Evidence for increased pulmonary capillary permeability. Am Rev Respir Dis 1972;106(3):472-4.
59. Urdaneta F, Lobato EB, Kirby RR, Horrow JC. Noncardiogenic pulmonary edema associated with protamine administration during coronary artery bypass graft surgery. J Clin Anesth 1999;11(8):675-81.
60. Larouche G, Denault A, Prenovault J. Corticosteroids and serious cytarabine-induced pulmonary edema. Pharmacotherapy 2000;20(11):1396-9.
61. Riegert-Johnson DL, Godfrey JA, Myers JL, Hubmayr RD, Sandborn WJ, Loftus Jr EV. Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion. Inflamm Bowel Dis 2002;8(3):186-91.
62. Dean NC, Amend WC, Matthay MA. Adult respiratory distress syndrome related to antilymphocyte globulin therapy. Chest 1987;91(4):619-20.
63. Verhoef G, Boogaerts M. Treatment with granulocytemacrophage colony stimulating factor and the adult respiratory distress syndrome. Am J Hematol 1991;36(4):285-7.
64. Ballen KK, Weiss ST. Fatal acute respiratory failure following vinblastine and mitomycin administration for breast cancer. Am J Med Sci 1988;295(6):558-60.
65. Konits PH, Aisner J, Sutherland JC, Wiernik PH. Possible pulmonary toxicity secondary to vinblastine. Cancer 1982;50(12):2771-4.
66. Hoelzer KL, Harrison BR, Luedke SW, Luedke DW. Vinblastine-associated pulmonary toxicity in patients receiving combination therapy with mitomycin and cisplatin. Drug Intell Clin Pharm 1986;20(4):287-9.
67. Van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJ, Demedts MG. Amiodarone and the development of ARDS after lung surgery. Chest 1994;105(6):1642-5.
68. Israel RH, Gross RA, Bomba PA. Adult respiratory distress syndrome associated with acute nitrofurantoin toxicity. Successful treatment with continuous positive airway pressure. Respiration (Herrlisheim) 1980;39(6):318-22.
69. Chudnofsky CR, Otten EJ. Acute pulmonary toxicity to nitrofurantoin. J Emerg Med 1989 Feb;7(1):15-9.